Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging

The EarlyCDT-Lung test is a high-specificity blood-based autoantibody biomarker that could contribute to predicting lung cancer risk. We report on the results of a phase IV biomarker evaluation of whether using the EarlyCDT-Lung test and any subsequent computed tomography (CT) scanning to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Frank M., Mair, Frances S., Anderson, William, Armory, Pauline, Briggs, Andrew, Chew, Cindy, Dorward, Alistair, Haughney, John, Hogarth, Fiona, Kendrick, Denise, Littleford, Roberta, McConnachie, Alex, McCowan, Colin, McMeekin, Nicola, Patel, Manish, Rauchhaus, Petra, Ritchie, Lewis, Robertson, Chris, Robertson, John, Robles-Zurita, Jose, Sarvesvaran, Joseph, Sewell, Herbert, Sproule, Michael, Taylor, Thomas, Tello, Agnes, Treweek, Shaun, Vedhara, Kavita, Schembri, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806972/
https://www.ncbi.nlm.nih.gov/pubmed/32732334
http://dx.doi.org/10.1183/13993003.00670-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806972/
https://www.ncbi.nlm.nih.gov/pubmed/32732334
http://dx.doi.org/10.1183/13993003.00670-2020

Ejemplares similares